tiprankstipranks
Trending News
More News >
Capstone Therapeutics Corp (CAPS)
NASDAQ:CAPS
US Market

Capstone Therapeutics (CAPS) Income Statement

Compare
49 Followers

Capstone Therapeutics Income Statement

Last quarter (Q3 2025), Capstone Therapeutics's total revenue was $13.65M, an increase of 10.85% from the same quarter last year. In Q3, Capstone Therapeutics's net income was $-2.01M. See Capstone Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 44.88M$ 48.35M$ 61.56M$ 66.74M$ 45.45M
Gross Profit
$ 9.57M$ 9.61M$ 16.53M$ 16.32M$ 10.94M
Operating Expenses
$ 10.21M$ 10.87M$ 12.54M$ 11.68M$ 8.54M
Depreciation and Amortization
$ 517.00K$ 306.00K$ 241.00K$ 386.00K$ 245.00K
EBITDA
$ -121.00K$ -1.75M$ 4.23M$ 5.02M$ 2.64M
Operating Income
$ -638.00K$ -1.26M$ 3.99M$ 4.64M$ 2.40M
Other Income/Expenses
$ -2.37M$ -2.33M$ -895.00K$ -279.00K$ -710.00K
Pretax Income
$ -3.00M$ -3.58M$ 3.10M$ 4.36M$ 1.69M
Net Income
$ -2.56M$ -3.82M$ 2.31M$ 3.92M$ 10.46M
Per Share Metrics
Basic EPS
$ -34.86$ -36.39$ 14.69$ 49.46$ 107.60
Diluted EPS
$ -34.86$ -36.39$ 14.69$ 49.46$ 107.60
Weighted Average Shares Outstanding
157.61K 157.61K 157.61K 79.28K 79.28K
Weighted Average Shares Outstanding (Diluted)
157.61K 157.61K 157.61K 79.28K 79.28K
Currency in USD

Capstone Therapeutics Earnings and Revenue History